GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Pre-Tax Income

Psyence Biomedical (Psyence Biomedical) Pre-Tax Income : $ Mil (TTM As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Psyence Biomedical's pretax income for the six months ended in Mar. 2023 was $-3.10 Mil. Psyence Biomedical does not have enough years/quarters to calculate the pretax income for the trailing twelve months (TTM) ended in Mar. 2023. Psyence Biomedical's pretax margin was %.


Psyence Biomedical Pre-Tax Income Historical Data

The historical data trend for Psyence Biomedical's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Pre-Tax Income Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
Pre-Tax Income
- -1.83 -3.10

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
Pre-Tax Income - -1.83 -3.10

Competitive Comparison of Psyence Biomedical's Pre-Tax Income

For the Biotechnology subindustry, Psyence Biomedical's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Biomedical's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Pre-Tax Income falls into.



Psyence Biomedical Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Psyence Biomedical's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-3.125+0.026+0+0.001+0.0010000000000003
=-3.10

Psyence Biomedical's Pretax Income for the quarter that ended in Mar. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-3.125+0.026+0+0.001+0.0010000000000003
=-3.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Psyence Biomedical  (NAS:PBM) Pre-Tax Income Explanation

Psyence Biomedical's Pretax Margin for the quarter that ended in Mar. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-3.097/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Psyence Biomedical Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Biomedical (Psyence Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines